1. Home Page
  2. About the OSUCCC – James
  3. Publications and Reports
  4. Magazines and Publications
  5. ImpactCancer
  6. 2017
  7. Spring
2017

impactCancer Spring 2017

With the recent conclusion of But for Ohio State – the most successful fundraising campaign in Ohio State’s 146-year history – we have taken another giant step toward creating a cancer-free world.

impactCancer Spring 2017

    Welcome

    With the recent conclusion of But for Ohio State – the most successful fundraising campaign in Ohio State’s 146-year history – we have taken another giant step toward creating a cancer-free world.

    The campaign, which began in 2009 and ended in September 2016, surpassed its goal of $2.5 billion by raising more than $3 billion from over 750,000 donors. Some $420.8 million of the monetary total was generated by our Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute (OSUCCC – James).

    That’s a huge contribution to a campaign that Ohio State University President Michael V. Drake, MD, called “historic,” noting that it will benefit our community and communities around the world for generations to come. The OSUCCC – James contribution is a tribute not only to those who spearheaded our efforts— including our superlative campaign medical director Ted Teknos, MD, and The James Foundation Board chaired by the tireless Lisa Hinson—but also to the generosity of our alumni and friends in the community who have stepped up to help us continue our important work.

    Another recently completed effort designed to help us end cancer is Pelotonia 16, the eighth installment of an annual grassroots bicycle tour that draws riders and donors from around the world to raise money for cancer research at Ohio State. Pelotonia 16, held last Aug. 6-7, raised a record $24.1 million, boosting the overall total for this event to more than $130 million. Details are in this issue of impactCancer.

    Also herein, you’ll find stories about: a new statewide initiative we launched in March through $3 million in Pelotonia funding that will help us take aim at lung cancer; the recent recruitment of Cheryl Taylore Lee, MD, a bladder cancer specialist who chairs the Department of Urology at Ohio State and whose work is also supported by Pelotonia dollars; profiles of grateful patients treated at the OSUCCC – James; and our 2016 Press Ganey Guardian of Excellence Award® for patient experience.

    I believe the contents of this issue signify that we’re on the right track for someday conquering cancer. I hope that you will agree.

    Michael A. Caligiuri, MD
    Director, The Ohio State University Comprehensive Cancer Center
    CEO, James Cancer Hospital and Solove Research Institute
    President, American Association for Cancer Research

    View the complete issue in PDF format

    OSUCCC – James Making ‘Ever-Bigger Footprint’ in Cancer Care

    Ohio State’s cancer program is placing “an ever-bigger footprint around the globe” as it continues to make an impact in research, compassionate care and community relationships, OSUCCC Director and James CEO Michael A. Caligiuri, MD, said during his 2016 “State of the Cancer Program Address.”

    Spreading the Word

    On Nov. 16 in New York City, approximately 40 people gathered to attend a regional reception of The James Ambassadors Society and learn more about research-based patient care taking place at the OSUCCC – James.

    Community Partners

    The OSUCCC – James Community Partners Program consists of corporations, individuals and community groups who raise funds in support of our vision to create a cancer-free world.

    From Grateful Patients

    Patients and families often express gratitude for the outstanding and compassionate care they receive at the OSUCCC – James. In these letters recently sent to OSUCCC – James leadership, our patients share about their exceptional care.